This study demonstrates enhanced abamectin removal in co-composting, suggesting optimal treatment conditions for antibiotic residues.
Aerobic co-composting represents an effective method for the treatment of antibiotic fermentation residues. This study optimized the co-composting of abamectin mycelial dregs (AMDs), excess sludge, and maize straw using an orthogonal experimental design. Composting was performed at a mass ratio of 4:1:1 (dry weight) under varying initial C/N ratios (20:1–30:1), moisture contents (50%–70%), and microbial inoculant dosages (5%–15%). Key parameters monitored included physicochemical properties, abamectin removal efficiency (RRA), and residual abamectin levels in the final product. The treatment with C/N = 30:1, moisture content = 60%, and inoculant dosage = 5% resulted in the longest thermophilic phase (6 days), highest temperature (59°C), highest germination index (90.05%), and highest RRA (89.67%), along with the lowest final moisture (24.95%) and residual abamectin (0.34 mg/g). Multivariate analysis of variance indicated that initial C/N, moisture, and inoculant dosage significantly influenced compost properties and abamectin degradation. Range analysis further identified the optimal conditions as C/N = 30:1, moisture = 70%, and inoculant = 5%. Microbial diversity analysis revealed key genera involved in the process, including Saccharomonospora, Bacillus, Kroppenstedtia, and Aspergillus. This study confirms the feasibility of aerobic co-composting for AMD treatment and offers new insights into its microbial mechanisms.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: